EPO and neoplasm: By contrast, the EPO-GEMM approach enables the production of autochthonous tumors in immunocompetent mice that naturally disseminate, enabling the relatively synchronous production of cohorts of tumor-bearing mice simply from a set of plasmids and commercially available immunocompetent WT mice.